Earnings Ahead

ABT - Abbott

107.28 2.01 1.91

Abbott

Abbott

About

Profile

We create breakthrough products – in diagnostics, medical devices, nutrition and branded generic pharmaceuticals – that help you, your family and your community lead healthier lives, full of unlimited possibilities. Today, 103,000 of us are working to


Headquarters

Chicago, Illinois, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

ABT



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Abbott Q2 results top consensus as base business offsets COVID impact
  • Abbott Laboratories Non-GAAP EPS of $1.08 beats by $0.03, revenue of $10B beats by $280M
  • Abbott seen reporting lower Q2 revenue, due in part to less COVID testing
  • Catalyst Watch: Microsoft-Activision Blizzard drama, Splunk event and Nasdaq 100 rebalancing countdown
  • Earnings week ahead: Tesla, Netflix, Johnson & Johnson, Bank of America and more
  • Goldman Sachs sees rays of hope in underperforming health sector
  • BTIG unveils top picks for rest of '23: D.R. Horton, CrowdStrike, DraftKings among names
  • FDA approves Abbott dual-chamber leadless pacemaker Aveir DR
  • Medicare revises guidance on drug price negotiations amid lawsuits
  • Abbott gains expanded coverage for glucose monitoring device in France
  • Abbott names Philip Boudreau CFO effective Sept. 1
  • Abbott Laboratories declares $0.51 dividend
  • Abbott alleges former scientist in its nutrition unit stole trade secrets
  • Morgan Stanley's top medtech picks are Medtronic, Alphatec, Becton Dickinson
  • Abbott, IQVIA, Global Fund, partners commit $54M to boost laboratory system for pandemics
  • Abbott boasts of heart failure reduction data for CardioMEMS device
  • Abbott, other baby-formula makers see FTC probe over collusion - report
  • Abbott recalled baby formula claims tossed by federal judge
  • Abbott gains approval of TactiFlex ablation catheter treatment
  • Stereotaxis stock rises after pact with Abbott to improve abnormal heartbeat treatment
Date Price Open High Low Vol Change
Apr 18 105.26 106.47
106.96
104.5
5.9M -0.59%
Apr 17 105.88 108.72
108.72
104.28
10.8M -3.08%
Apr 16 109.25 108.84
110.33
108.14
5.9M 0.35%
Apr 15 108.87 110.17
110.87
108.84
3.4M -0.2%
Apr 12 109.09 110.22
110.5
108.49
3.1M -2.08%
 
Apr 11 111.41 111.68
111.89
110.32
3.1M 0.22%
Apr 10 111.17 111.07
111.63
110.38
3.5M -1.13%
Apr 9 112.44 110.65
112.56
110.64
4.2M 1.71%
Apr 8 110.55 111.37
111.37
110.14
4.2M -0.58%
Apr 5 111.2 110.06
111.26
109.93
5.6M 0.99%
Apr 4 110.11 111.98
111.98
109.84
4.7M -1.05%
Apr 3 111.28 112.16
112.55
111.05
4.3M -0.66%
Apr 2 112.02 111.92
112.42
111.19
4.6M -0.06%
Apr 1 112.09 113.6
113.61
111.82
3.8M -1.38%
Mar 28 113.66 113.28
114.01
112.94
5.3M 0.16%
Mar 27 113.48 112.12
113.7
112.08
7.5M 1.78%
Mar 26 111.5 110.42
111.89
109.97
7.8M 1.35%
Mar 25 110.01 110.46
110.7
109.13
6.6M -0.5%
Mar 22 110.56 111.52
111.98
110.55
4.0M -0.8%
Mar 21 111.45 111.95
112.14
111.02
7.8M -0.04%
Mar 20 111.5 113
113.24
110.73
8.3M -1.47%
Mar 19 113.16 112.44
114.42
112.04
8.3M 0.64%
Mar 18 112.44 115.35
115.76
112.29
13.0M -2.64%
Mar 15 115.49 113.02
115.49
112.26
22.1M -2.83%
Mar 14 118.85 120.01
120.34
117.85
4.9M -1.09%
Mar 13 120.16 120.52
120.93
119.62
3.4M -0.5%
Mar 12 120.76 119.95
121.08
119.06
3.1M 0.47%
Mar 11 120.19 120.93
121.42
119.62
3.9M -0.64%
Mar 8 120.96 120.97
121.64
120.61
3.4M 0.03%
Mar 7 120.92 120.1
121.5
119.95
4.1M 1.32%
Mar 6 119.34 118.6
119.58
118.42
3.4M 0.73%
Mar 5 118.48 120.44
120.6
118.08
3.5M -1.3%
Mar 4 120.04 118.3
120.28
118.17
3.1M 1.20%
Mar 1 118.62 118.57
119.46
117.83
3.9M -0.02%
Feb 29 118.64 120.32
120.44
118.53
6.1M -1.17%
Feb 28 120.05 119.49
120.11
119.27
3.4M 0.54%
Feb 27 119.4 118.16
119.5
117.83
3.2M 0.60%
Feb 26 118.69 119.5
119.95
118.39
3.4M -0.64%
Feb 23 119.46 119.38
120.15
118.86
4.3M 0.37%
Feb 22 119.02 118.1
119.25
116.8
4.9M 0.98%
Feb 21 117.87 115.96
117.97
115.96
6.1M 1.05%
Feb 20 116.64 114.33
117.19
113.96
9.6M 2.31%
Feb 16 114.01 113.5
115.49
113.45
7.2M 0.33%
Feb 15 113.64 112.27
114.27
112.27
5.4M 1.41%
Feb 14 112.06 111.64
112.38
111.12
4.0M 0.65%
Feb 13 111.34 112.47
113.11
110.58
4.2M -1.06%
Feb 12 112.53 111.5
112.63
111.21
4.2M 0.64%
Feb 9 111.81 112.25
112.63
111.19
5.9M -0.55%
Feb 8 112.43 113.35
113.35
111.52
6.9M -0.78%
Feb 7 113.31 114.6
114.6
112.89
4.7M -0.61%
Feb 6 114 111.82
114.51
111.72
4.7M 2.10%
Feb 5 111.65 112.02
112.46
111.15
5.7M -0.41%
Feb 2 112.11 112.96
114.06
111.98
7.6M -2.08%
Feb 1 114.49 112.75
114.54
112
4.5M 1.18%
Jan 31 113.15 114
114.54
112.62
8.3M -0.29%
Jan 30 113.48 113.9
113.92
112.38
4.7M 0.03%
Jan 29 113.45 112.15
113.47
112.03
6.5M 1.29%
Jan 26 112.01 113.23
113.41
111.54
5.2M -0.39%
Jan 25 112.45 111.41
112.57
110.79
5.6M 1.52%
Jan 24 110.77 110.75
113.35
109.74
8.7M 0%